AN2 Therapeutics
ANTX
#8920
Rank
โ‚น17.86 B
Marketcap
โ‚น470.71
Share price
-2.68%
Change (1 day)
382.01%
Change (1 year)

Earnings for AN2 Therapeutics (ANTX)

Earnings in 2026 (TTM): -โ‚น3.56 Billion

According to AN2 Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น3.54 Billion, an increase over its 2024 earnings that were of -โ‚น5.06 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AN2 Therapeutics from 2021 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น3.56 Billion0.81%
2025 -โ‚น3.54 Billion-30.14%
2024 -โ‚น5.06 Billion-21.66%
2023 -โ‚น6.46 Billion64.77%
2022 -โ‚น3.92 Billion95.89%
2021 -โ‚น2 Billion